Bayhill Therapeutics Obtains $54,293,100 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2609ccdd-66d3-4b5a-96cf-b9c8592c888b&Preview=1 -
Date
12/31/2008 -
Company Name
Bayhill Therapeutics -
Mailing Address
1804 Embarcadero Road Palo Alto, CA 94303 -
Company Description
Bayhill Therapeutics Inc. is focused on the translation of research into therapeutics by developing novel drugs for the treatment of autoimmune diseases. -
Website
http://www.bayhilltherapeutics.com/ -
Transaction Type
Venture Equity -
Transaction Amount
$54,293,100 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Morgenthaler Ventures -
Venture Investor
De Novo Ventures -
Venture Investor
U.S. Venture Partners
